BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 8, 2013
View Archived Issues
Optimal dose of PM-00104 determined in phase II multiple myeloma study
Read More
OncoTherapy patents novel potential cancer vaccines
Read More
University of California discloses novel NGF muteins
Read More
The discovery of a cell signaling molecule that protects against diet-induced insulin resistance
Read More
Results reported from phase II study of chaperone-ERT in Pompe's disease
Read More
Novel molecular techniques to prevent immune rejection following pancreatic islet transplantation
Read More
New microfluidic platform developed for the highly sensitive detection of malaria
Read More
Clinical evaluation of the safety and tolerability of HIV vaccine alternative
Read More
SymBio receives trial notification acceptance for phase II Treakisym trial
Read More
Japan Tobacco files JTT-751 NDA in Japan
Read More
Pazopanib/paclitaxel combination found potentially beneficial for anaplastic thyroid cancer
Read More
European orphan drug designation recommended for VAL-083 for glioma
Read More
EnVivo Pharmaceuticals begins phase II trial of EVP-0962 in Alzheimer's disease
Read More
Labrys Biologics acquires antibody for chronic migraine from Pfizer
Read More
Scil Proteins presents new fusion proteins for cancer and infections
Read More
Edison Pharmaceuticals commences phase IIb trial in Friedreich's ataxia
Read More
Chinese scientists prepare novel protein kinase receptor antagonists
Read More
Agios Pharmaceuticals presents new IDH1 inhibitors
Read More
CrystalGenomics reports topline data from phase IIa CG-400549 study
Read More
CalciMedica presents new calcium channel blockers
Read More
EntreMed files trial application in China, opens second trial site in U.S., for ENMD-2076
Read More
BioMarin Pharmaceutical acquires Zacharon Pharmaceuticals
Read More
Oravig launched in U.S.
Read More
Durata Therapeutics' DISCOVER 1 trial meets primary endpoints
Read More
Boehringer Ingelheim and Eli Lilly report topline data for empagliflozin
Read More
First-in-human phase Ib study of ARGX-110 begins
Read More
